Viewing Strategy Training in Children With (Cerebral) Visual Impairment
NCT ID: NCT05600140
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-10-25
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The current project has two goals: (1) to measure viewing strategies used by children with normal vision, children with ocular visual impairment and children with CVI, and (2) to evaluate whether training viewing strategies results in more efficiƫnt visual Information processing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors in Learning And Plasticity: Healthy Vision
NCT05439759
In-person and Telehealth Visual Rehabilitation for Children With Low Vision
NCT06701617
Mechanisms of Perceptual Learning
NCT06822101
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
NCT06670989
Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
NCT06997354
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
In the second phase of the project, children receive a visual training of viewing strategies (six weeks, 2 times a week, 30 minutes). During the training, children are instructed to use specific viewing strategies (looking in a structured direction which fits the task at hand, zooming in and out / change of visual selective attentional field, visual discrimination). The verbal instructions and exercises are protocol based. A textbook is used to describe the reactions of the children during training.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A) early training group
T0 = baseline measurement T1 = posttest (within two weeks after training) T2 = follow up measurement (6 months after training)
Viewing strategy training
Children receive a visual training of viewing strategies (six weeks, 2 times a week, 30 minutes). During the training, children are instructed to use specific viewing strategies (looking in a structured direction which fits the task at hand, zooming in and out / change of visual selective attentional field, visual discrimination). The verbal instructions and exercises are protocol-based. A textbook is used to describe the reactions of the children during training.
Group B) late training group
T0 = baseline measurement T1 = test-retest reliability and natural development (over period 1 1/2-2 months after T0) T2 = posttest (within two weeks after training)
Viewing strategy training
Children receive a visual training of viewing strategies (six weeks, 2 times a week, 30 minutes). During the training, children are instructed to use specific viewing strategies (looking in a structured direction which fits the task at hand, zooming in and out / change of visual selective attentional field, visual discrimination). The verbal instructions and exercises are protocol-based. A textbook is used to describe the reactions of the children during training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Viewing strategy training
Children receive a visual training of viewing strategies (six weeks, 2 times a week, 30 minutes). During the training, children are instructed to use specific viewing strategies (looking in a structured direction which fits the task at hand, zooming in and out / change of visual selective attentional field, visual discrimination). The verbal instructions and exercises are protocol-based. A textbook is used to describe the reactions of the children during training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* linear distant visual acuity of 0.1 logMAR or better
* Verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D
* Age 5-12 years
* Children with linear distance visual acuity better \<=1.3logMAR and \>0.1 logMAR
* Intact central visual field (at least \> 30 degrees)
* Children with a verbal IQ above 70
* Absence of developmental disorders or psychiatric problems like ASS or AD(H)D
* Age 5-12 years
* Linear distance visual acuity \<=0.3 logMAR
* Having the diagnosis CVI (verified by ophthalmologists)
* Children with a verbal IQ above 70
* Absence of psychiatric problems like ASS or AD(H)D
Additional inclusion criterion for study 2 (evaluating training effectiveness): children with (cerebral) visual impairment should have an indication for viewing strategy training. Training should not be indicated if children have no problems performing academic tasks (i.e. when speed and accuracy of visual processing is within the normal range). The age range for study 2 is 5-9 years.
Exclusion Criteria
* Children with visual field defect \< 30 degrees
* Children with a verbal IQ below 70
* Children who attended a form of vision training in the past two years
* Children with psychiatric problems like ASS or AD(H)D
* Auditory impairment or language impairments
* Major life events during training
5 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University, Behavioural Science Institute, Nijmegen, The Netherlands
UNKNOWN
Royal Dutch Visio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bianca Huurneman, PhD
Role: PRINCIPAL_INVESTIGATOR
Royal Dutch Visio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Dutch Visio
Nijmegen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hanna Romema, MSc
Role: primary
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL81584.091.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.